İlay Berke

418 total citations
12 papers, 49 citations indexed

About

İlay Berke is a scholar working on Nephrology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, İlay Berke has authored 12 papers receiving a total of 49 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Nephrology, 3 papers in Genetics and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in İlay Berke's work include Renal Diseases and Glomerulopathies (5 papers), Vasculitis and related conditions (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). İlay Berke is often cited by papers focused on Renal Diseases and Glomerulopathies (5 papers), Vasculitis and related conditions (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). İlay Berke collaborates with scholars based in Türkiye, Austria and United Kingdom. İlay Berke's co-authors include Andreas Kronbichler, Annette Bruchfeld, Eleni Frangou, Münci Yağcı, Zübeyde Nur Özkurt, Zeynep Arzu Yeğin, Dimitrios Goumenos, María José Soler, Jürgen Floege and Sarah Moran and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nephrology Dialysis Transplantation and Current Rheumatology Reports.

In The Last Decade

İlay Berke

11 papers receiving 49 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
İlay Berke Türkiye 5 26 12 11 11 7 12 49
David Philibert Canada 5 42 1.6× 5 0.4× 8 0.7× 10 0.9× 9 1.3× 5 61
Sindhura Lakshmi Koulmane Laxminarayana India 4 16 0.6× 5 0.4× 4 0.4× 5 0.5× 2 0.3× 22 45
Rebecca Hudson Australia 4 31 1.2× 10 0.8× 6 0.5× 15 1.4× 1 0.1× 8 47
Jillian K. Warejko United States 3 29 1.1× 4 0.3× 12 1.1× 6 0.5× 1 0.1× 6 44
Adrian Lungu Romania 5 23 0.9× 2 0.2× 11 1.0× 3 0.3× 9 1.3× 10 46
Cécile Kerloëguen Switzerland 3 34 1.3× 16 1.3× 2 0.2× 10 0.9× 3 0.4× 5 64
Catalina Martín Cleary Spain 1 22 0.8× 3 0.3× 10 0.9× 2 0.2× 4 0.6× 2 42
A. Mahfoud Tunisia 4 37 1.4× 7 0.6× 38 3.5× 5 0.5× 42 6.0× 4 91
Majda Benedik‐Dolničar Slovenia 6 6 0.2× 10 0.8× 8 0.7× 2 0.2× 14 2.0× 12 59
Fabio Lizzi Germany 3 23 0.9× 16 1.3× 3 0.3× 3 0.3× 3 0.4× 3 40

Countries citing papers authored by İlay Berke

Since Specialization
Citations

This map shows the geographic impact of İlay Berke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by İlay Berke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites İlay Berke more than expected).

Fields of papers citing papers by İlay Berke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by İlay Berke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by İlay Berke. The network helps show where İlay Berke may publish in the future.

Co-authorship network of co-authors of İlay Berke

This figure shows the co-authorship network connecting the top 25 collaborators of İlay Berke. A scholar is included among the top collaborators of İlay Berke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with İlay Berke. İlay Berke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Murt, Ahmet, İlay Berke, Annette Bruchfeld, et al.. (2025). Malignancies and glomerulonephritis: when to suspect and when to screen?. Clinical Kidney Journal. 18(5). sfaf101–sfaf101. 2 indexed citations
2.
Berke, İlay & Andreas Kronbichler. (2024). Reclassifying ANCA-associated vasculitis: a focus on kidney disease. The Lancet Rheumatology. 6(11). e736–e737.
3.
Ivković, Vanja, Martin Windpessl, İlay Berke, et al.. (2024). ANCA-Associated Glomerulonephritis: Diagnosis and Therapy Proceedings of the Henry Shavelle Lectureship. SHILAP Revista de lepidopterología. 5(1). 26–47. 1 indexed citations
4.
Berke, İlay, et al.. (2024). Clinical outcomes in peritoneal dialysis with refractory peritonitis: significance of the day 5 cell count. Clinical and Experimental Nephrology. 29(2). 221–226. 1 indexed citations
5.
Berke, İlay, et al.. (2024). AA Amyloidosis: A Contemporary View. Current Rheumatology Reports. 26(7). 248–259. 8 indexed citations
6.
Berke, İlay, Ingeborg M. Bajema, Annette Bruchfeld, et al.. (2024). Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group. Nephrology Dialysis Transplantation. 39(4). 569–580. 14 indexed citations
7.
Berke, İlay & Andreas Kronbichler. (2023). Inhibition of clonal expansion of parietal epithelial cells and crescent–podocyte transition in severe glomerulonephritis: on the way to targeted therapy?. Clinical Kidney Journal. 16(7). 1057–1058. 4 indexed citations
8.
9.
Windpessl, Martin, Myrto Kostopoulou, Richard Conway, et al.. (2023). Preventing infections in immunocompromised patients with kidney diseases: vaccines and antimicrobial prophylaxis. Nephrology Dialysis Transplantation. 38(Supplement_2). ii40–ii49. 7 indexed citations
10.
Berke, İlay, et al.. (2021). Course of COVID-19 Pneumonia in a Kidney Transplant Patient Receiving Eculizumab. Progress in Transplantation. 31(3). 279–280. 2 indexed citations
11.
Berke, İlay, et al.. (2018). Prognostic Significance of Serum BAFF, APRIL, TACI and BCMA Levels in Chronic Lymphocytic Leukemia. Indian Journal of Hematology and Blood Transfusion. 35(2). 265–271. 8 indexed citations
12.
Özcebe, Hilal, et al.. (2012). Health Promoting Behaviors and the Expectations for the Environment of the Hospital Administrative Staff. TAF Preventive Medicine Bulletin. 11(6). 707–707. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026